Leadership Team

Joe Massaro, Chief Financial Officer for inVentiv Health, has more than 18 years of experience as a finance executive in complex service, distribution, and manufacturing organizations.

Before joining inVentiv Health, Mr. Massaro was a Managing Director at Liberty Lane Partners, LLC, a private investment firm that applies its unique operational and financial expertise to its portfolio companies to achieve above-market returns.

Prior to joining Liberty Lane Partners, Mr. Massaro served in several senior financial and operational roles
at Thermo Fisher Scientific, including Senior Vice President Global Business Services and Vice President Corporate Finance and Accounting. In addition, Mr. Massaro served as Vice President Strategic Planning
at Fisher BioPharma Services, a division of Thermo Fisher Scientific focused on providing outsourced clinical trial management and logistics to the pharmaceutical and biotechnology industries. Prior to Thermo Fisher, Mr. Massaro served in various capacities in the advisory business services practice at PricewaterhouseCoopers
in Boston.

Mr. Massaro holds a bachelor’s degree from Bentley University. He holds a master’s degree in accounting
and an MBA from Northeastern University.

Robert Chandler is inVentiv Health’s Senior Vice President of Marketing and Communications and Head of inVentiv Health Communications/Europe overseeing the company’s European communications businesses and global brand-building activities. Mr. Chandler is also co-founder of Chandler Chicco Companies, part of inVentiv Health since 2007.

Mr. Chandler is one of the healthcare industry’s most experienced communications consultants. In 1995, he and business partner, Gianfranco Chicco, founded Chandler Chicco Agency (CCA), which quickly grew to become Chandler Chicco Companies (CCC) providing best-in-class PR, digital, medical education, marketing, branding, design, and research and measurement. CCC has won some of the most prestigious awards in the industry, including The Holmes Report Healthcare Agency of the Decade (2000-2010), Healthcare Agency of the Year (2002-2009), Specialist Agency of the Year (2006-2007), and Creative Agency of the Year (2006); and PRWeek’s Number 1 European Healthcare Consultancy (2008-2011), and Agency of the Year & Midsize Agency of the Year (2007). With revenue exceeding $80 million, CCC has offices in New York, London, Los Angeles, Washington D.C., Frankfurt and Paris with a global affiliate network spanning 37 markets worldwide.

Previously, Mr. Chandler was Executive Vice-President and Co-Managing Director of Burson-Marsteller’s healthcare practice and president of the agency’s The Biotech Group. He also served as VP/assistant administrator for marketing and public affairs at Methodist Hospital in Brooklyn.

In 2007, Mr. Chandler was awarded the Ohio University Alumni Medal of Merit and in 2010, he received an Individual Achievement Award from The Holmes Report.

Mr. Chandler has a BS in Journalism from Bowling Green State University; an MS in Journalism from Ohio University; and an MBA in Health Services Administration from Wagner College.

Mr. Chandler sits on the Board of Directors of The Ranney School in New Jersey.

Kris Coombs leads the corporate Human Resources team. Mr. Coombs has been with inVentiv Health since 2007, leading the talent management team and was previously the head of human resources at Kao Brands, a billion dollar consumer products company with such brands as Jergens, Bioré, and John Frieda Hair Care.

In his role as Chief Human Resources Executive, Mr. Coombs focuses on talent acquisition and management, compensation planning, benefits, global human resources policies and programs, and employee issues related to acquisitions. He is based in inVentiv Health’s corporate headquarters in Burlington, Massachusetts.

Mr. Coombs holds a bachelor’s degree in business administration from Xavier University.

Mark Dmytruk is President of inVentiv Health Patient Outcomes, a subsegment of the inVentiv Health Commercial segment. He is based at inVentiv Health’s headquarters in Burlington, Massachusetts.

Mr. Dmytruk has extensive experience in the healthcare, life sciences, and diagnostics industries, including emerging and international market development. He joined inVentiv Health from Athena Diagnostics, where he was Vice President of Finance and a member of the executive management team. Prior to Athena, Mr. Dmytruk led Corporate Development at Thermo Fisher Scientific, where he managed merger and acquisition activity worldwide and contributed to revenue growth of more than 300 percent in eight years.

Mr. Dmytruk holds a bachelor’s degree from the University of Alberta in Edmonton, Canada, and an MBA
from the Massachusetts Institute of Technology (MIT).

Rick Finnegan is Executive Vice President of International Business in the company’s Commercial segment.
In this role, he drives the strategy for expanding the Commercial business internationally and oversees planning for the company’s growth in markets outside the United States.

Since 2009, inVentiv Health’s global footprint in clinical, commercial, and consulting services has grown significantly. This includes the launch of inVentiv Health Japan in 2009, a business that is now among the largest contract sales organizations (CSO) in Japan.

Mr. Finnegan joined inVentiv Health with more than 25 years of experience in the pharmaceutical industry, serving in executive roles for a variety of companies ranging from large corporations to start-up ventures.
He served most recently at Glenmark Therapeutics, a specialty pharmaceutical company based in Mumbai, India, where he led its central/eastern European division as Senior Vice President of Specialty Pharmaceuticals based in Prague, Czech Republic. Prior to Glenmark, Mr. Finnegan spent more than a decade at Merck in marketing leadership positions of increasing responsibility, including Senior Director Worldwide of New Products/Anti-Infectives in the Worldwide Human Health Marketing Division.

Mr. Finnegan holds a bachelor’s degree in business administration and life sciences from the University
of New Hampshire, and he holds a master’s degree from the Sloan School of Management at MIT.

Kelly Gratz’s most recent responsibilities include serving as President of inVentiv Health Selling Accelerators, championing the integration across the Commercial Division. She has a unique blend of experience, holding senior positions within inVentiv’s communications and commercial divisions, and leading collaborative initiatives across all segments of the business.

Kelly has been at the forefront of ReAgent™, a proprietary methodology to strategically allocate and optimize commercialization resources. Kelly also brings direct experience in driving topline growth for brands in an outsourced, risk sharing model as well as operational experience.

Since joining inVentiv Health in 2000, Kelly has been directly involved in driving multi-channel success for a number of pharmaceutical clients, including Ortho-McNeil Neurologics, Merck, Ethicon, TAP, BMS, Eli Lilly and Company, Genentech, AstraZeneca, GlaxoSmithKline, Ross Products, Takeda, and UCB Pharma.

Prior to inVentiv Health, Kelly served in an executive management position for Symix Systems, a marketer and developer of e-business software. Previous to Symix, Kelly spent over 10 years with Ernst & Young LLP in their management consulting group, working with Fortune 500 companies to improve processes and increase overall efficiencies throughout each organization.

Mike Ivers, Chief Operating Officer of PharmaNet/i3, actively participates in and leads day-to-day operations to enhance PharmaNet/i3's productivity and client service.

In his previous role as Executive Vice President of inVentiv Health, Mr. Ivers played a lead role in driving the integration and growth of the company’s expanding Clinical segment. He also helped support the formulation and implementation of inVentiv’s overall global growth strategy.

Mr. Ivers has more than 30 years of experience in the pharmaceutical and drug development industry. He served as Global President of Fisher BioPharma Services and later as Division President of ThermoFisher, where he successfully built the division into a $700 million industry leader. Previously, Mr. Ivers served at Covance as Vice President and General Manager overseeing the global clinical supplies business. He also held corporate roles at the company in the U.S. and Europe.

Prior to Covance, Mr. Ivers worked for 18 years at SmithKline Beecham in a variety of management roles including finance, marketing, product development, strategic planning and operational management.

Mr. Ivers originates from the U.K., where he initially started his career in finance, working in both private practice and industry after qualifying as a Chartered Accountant.

Jeffrey McMullen is President of inVentiv Health’s Clinical segment, PharmaNet/i3.

Mr. McMullen has more than 35 years of experience in the drug development industry in the United States, Europe, South America, and Asia. In 1983, Mr. McMullen joined a small CRO of 15 people, holding leadership positions in clinical and business development roles.

In 1989, the Company was sold to Corning and became the foundation of the Covance clinical development business. In 1996, he co-founded PharmaNet. His professional experience includes 13 years with major drug development services companies as Vice President of Business Development and Director of Clinical Research, and nine years at Sterling Drug (now Sanofi) in the clinical, regulatory, and drug metabolism areas.

Mr. McMullen is focused on the continued growth and global expansion of the organization.

Mr. Mignon successfully leads inVentiv Health Selling Solutions, which encompasses all of the companies
that relate to sales teams and sales support services.

In his current role, Mr. Mignon is responsible for the development and execution of comprehensive, customized selling solutions that support many of the major pharmaceutical firms, as well as effectively delivering cross-selling and integrated solutions to clients that include services across the broader inVentiv Health organization.

Mr. Mignon joined inVentiv Health in 2002 when he assumed the leadership role for the sales organization. Since that time, he has expanded the active client roster and significantly diversified their service portfolio.
As a consultative business partner, Mr. Mignon has strengthened and stabilized client relationships by providing innovative products and services to meet the challenges of the dynamic pharmaceutical marketplace.

Mr. Mignon’s depth of experience is built on a successful 14-year career with Johnson & Johnson. During his tenure, he was recognized for many significant accomplishments while holding various leadership roles within the Johnson & Johnson family of companies, including National Sales Director, Sales Training Director, Product Director, and Division Manager.

Mr. Mignon is a graduate of Lafayette College, where he holds a bachelor’s degree in history. He is a member of the editorial board for Product Management Today and serves on the Board of Directors for the Cancer Institute of New Jersey.

As Chief Executive Officer of Campbell Alliance, inVentiv Health’s Consulting segment, Mr. Naeymi-Rad oversees the six consulting practice areas at Campbell Alliance and works to refine core business processes and improve operational alignment among the practice areas. These efforts include enhancing methods and tools, identifying and shaping new service offerings and new potential practice areas, and leading the firm’s next generation approach to account management.

Prior to becoming Chief Executive Officer, Mr. Naeymi-Rad played a pivotal role in the growth of the firm, specifically its Brand Management Practice. The practice currently has more than 80 consulting professionals around the world, and under Mr. Naeymi-Rad’s leadership, it has maintained at least 35 percent year-over-year revenue growth since its inception. He has worked on more than 500 client projects with pharmaceutical and biotech companies in a dozen countries across North America, the United Kingdom, Europe, and Asia.

Mr. Naeymi-Rad has been published in numerous industry journals and is a frequent speaker at industry conferences, covering topics related to developing and implementing commercial strategies and improving commercial processes.

He holds a bachelor’s degree from Georgetown University.

As President of inVentiv Health Communications, Bill O’Donnell is responsible for strategic direction and oversight of inVentiv Health Communications, a subsegment of inVentiv Health Commercial. He also oversees client relationships, new business activities and the subsegment’s operational backbone that includes the accounting/finance, human resources, marketing communications, and technology departments.

Prior to joining inVentiv Health Communications (then inChord) in 2001, Mr. O’Donnell was Chief Financial Officer (CFO) for Bank One’s Retail Customer and Channel Group (now JPMorgan Chase). In this role, he led a team of finance and accounting professionals to provide decision support, financial reporting and analysis, financial control, and strategic and capital planning for a business unit management team. During Mr. O’Donnell’s 17 years with Bank One, he held a number of other positions, including CFO of the Business Banking Group, where he was responsible for the financial management of the small business unit. He also served as a liaison between the retail line of business CFO and Chief Executive Officer and the Bank One Corporation CFO and Chief Operating Officer.

Mr. O’Donnell holds a bachelor’s degree in finance and accounting from Miami University and an MBA from the University of Dayton. He also completed the Executive Development Program at the University of Virginia’s Darden School of Business.